CN1358228A - 来自基质细胞的多核苷酸序列和推断的氨基酸序列 - Google Patents

来自基质细胞的多核苷酸序列和推断的氨基酸序列 Download PDF

Info

Publication number
CN1358228A
CN1358228A CN00807774A CN00807774A CN1358228A CN 1358228 A CN1358228 A CN 1358228A CN 00807774 A CN00807774 A CN 00807774A CN 00807774 A CN00807774 A CN 00807774A CN 1358228 A CN1358228 A CN 1358228A
Authority
CN
China
Prior art keywords
leu
gly
val
sequence
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00807774A
Other languages
English (en)
Chinese (zh)
Inventor
L·斯特拉钱
M·斯莱曼
N·阿伯尼斯
R·安鲁斯特
K·D·库姆布勒
J·G·穆里森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genesis Research and Development Corp Ltd
Original Assignee
Genesis Research and Development Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Research and Development Corp Ltd filed Critical Genesis Research and Development Corp Ltd
Publication of CN1358228A publication Critical patent/CN1358228A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN00807774A 1999-03-25 2000-02-18 来自基质细胞的多核苷酸序列和推断的氨基酸序列 Pending CN1358228A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27626899A 1999-03-25 1999-03-25
US09/276,268 1999-03-25
US09/383,586 US6242419B1 (en) 1999-03-25 1999-08-26 Compositions isolated from stromal cells and methods for their use
US09/383,586 1999-08-26

Publications (1)

Publication Number Publication Date
CN1358228A true CN1358228A (zh) 2002-07-10

Family

ID=26957887

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00807774A Pending CN1358228A (zh) 1999-03-25 2000-02-18 来自基质细胞的多核苷酸序列和推断的氨基酸序列

Country Status (9)

Country Link
US (1) US6242419B1 (https=)
EP (1) EP1163334A4 (https=)
JP (1) JP2002539827A (https=)
CN (1) CN1358228A (https=)
AU (1) AU782974B2 (https=)
CA (1) CA2368477A1 (https=)
HK (1) HK1048137A1 (https=)
NZ (1) NZ514329A (https=)
WO (1) WO2000058463A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074897B2 (en) * 1997-06-16 2006-07-11 Genentech, Inc. Pro943 polypeptides
US20030143676A1 (en) * 1999-03-25 2003-07-31 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
US6743907B1 (en) * 1999-10-19 2004-06-01 Lexicon Genetics Incorporated Human proteins and polynucleotides encoding the same
EP1240198A4 (en) * 1999-10-19 2003-11-05 Millennium Pharm Inc GENES ENCODING PROTEINS WITH PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND OTHER APPLICATIONS
US7348162B2 (en) * 2000-03-22 2008-03-25 Amgen Inc. Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof
WO2001092495A2 (en) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. A human lysyl ixodase (47765) and uses thereof
US6812002B2 (en) * 2000-08-30 2004-11-02 Pfizer Inc. Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
JP2002272470A (ja) * 2001-03-21 2002-09-24 Takashi Nakamura リジルオキシダーゼ関連タンパク質をコードする核酸
EP1508340A4 (en) 2002-05-24 2009-07-01 Takeda Pharmaceutical MEANS FOR IMPROVING INSULIN RESISTANCE
WO2004042019A2 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
EP1597577A4 (en) * 2003-02-10 2007-02-21 Pointilliste Inc SELF-ARRANGING ARRAYS AND ITS APPLICATION
WO2005040205A1 (en) * 2003-10-28 2005-05-06 Protemix Discovery Limited Peptides with anti-obesity activity and other related uses
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
US20090297479A1 (en) * 2008-03-28 2009-12-03 Kiyoshi Ariizumi Dc-hil conjugates for treatment of t-cell disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009327A2 (en) * 1999-07-28 2001-02-08 Genentech, Inc. Method of preventing the injury or death of retinal cells and treating ocular diseases
CA2328895A1 (en) 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000024756A1 (en) 1998-10-23 2000-05-04 Human Genome Sciences, Inc. Fibroblast growth factor receptor-5
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2495200A (en) * 1999-03-08 2000-09-28 Genentech Inc. Compositions and methods for the treatment of tumor
ATE478145T1 (de) * 1999-06-02 2010-09-15 Genentech Inc Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
AU5907800A (en) * 1999-06-30 2001-01-31 Millennium Pharmaceuticals, Inc. Membrane-associated and secreted proteins and uses thereof
WO2001053312A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001238488A1 (en) * 2000-02-17 2001-08-27 Incyte Genomics, Inc. Human kinases

Also Published As

Publication number Publication date
US6242419B1 (en) 2001-06-05
HK1048137A1 (zh) 2003-03-21
NZ514329A (en) 2003-07-25
AU2702100A (en) 2000-10-16
CA2368477A1 (en) 2000-10-05
JP2002539827A (ja) 2002-11-26
EP1163334A4 (en) 2004-07-28
EP1163334A1 (en) 2001-12-19
AU782974B2 (en) 2005-09-15
WO2000058463A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
CN1107072C (zh) 编程性细胞死亡诱导分子ⅱ
CN1105187C (zh) 原钙粘着蛋白蛋白质及其应用
CN1184315C (zh) 包含死亡结构域的受体－5
CN1267550C (zh) 血管内皮生长因子2
CN1146440C (zh) 血管内皮生长因子-b
CN1358228A (zh) 来自基质细胞的多核苷酸序列和推断的氨基酸序列
CN1446227A (zh) 新型成纤维细胞生长因子(fgf23)及其使用方法
CN1197966C (zh) 肿瘤坏死因子受体相关因子的调节剂、及其制备和用途
CN1552855A (zh) 人血管内皮生长因子2
CN1232469A (zh) 刺激神经和肾生长的RET配体(RetL)
CN1474869A (zh) 新型化合物
CN1308451C (zh) 肿瘤坏死因子相关配基
CN1367829A (zh) 用于肺癌治疗和诊断的组合物和方法
CN1260835A (zh) 截短的vegf相关蛋白质
CN1272884A (zh) 脂肪细胞特异性蛋白质同系物
CN1444599A (zh) 新型化合物
CN1464057A (zh) 具有骨骼肌刺激活性和免疫调节作用的趋化素样因子超家族
CN1414020A (zh) 成纤维细胞生长因子11的抗体、拮抗剂及激动剂
CN1399644A (zh) 新的人g蛋白偶联受体
CN1169954C (zh) 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸
CN1353754A (zh) 用作TNF－α信号传导途径抑制物的TRAF2变体
CN1371421A (zh) 坦科聚合酶2材料和方法
CN1169956C (zh) 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸
CN1193041C (zh) 具有抑制癌细胞生长功能的人蛋白及其编码序列
CN1703422A (zh) Meth1和meth2多核苷酸及多肽

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1048137

Country of ref document: HK